Singapore markets open in 4 hours 46 minutes
Straits Times Index
3,303.66 +12.96 (+0.39%) S&P 500
5,221.42 -1.26 (-0.02%) Dow
39,431.51 -81.33 (-0.21%) Nasdaq
16,388.24 +47.37 (+0.29%) Bitcoin USD
63,102.53 +1,763.02 (+2.87%) CMC Crypto 200
1,297.20 +36.99 (+2.94%)
GSK May 2024 28.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:13PM EDT. Market open.
| Previous close | 15.10 |
| Open | 15.10 |
| Bid | 11.70 |
| Ask | 15.20 |
| Strike | 28.00 |
| Expiry date | 2024-05-17 |
| Day's range | 15.10 - 15.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 9 |
Simply Wall St.GSK plc (LON:GSK) Stock Goes Ex-Dividend In Just Four Days
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see GSK plc...
- Simply Wall St.
GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
GlobeNewswireBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections
© 2024 Yahoo. All rights reserved.